SANA logo

Sana Biotechnology (SANA) EBITDA

annual EBITDA:

-$255.33M+$13.25M(+4.93%)
December 31, 2024

Summary

  • As of today (June 17, 2025), SANA annual EBITDA is -$255.33 million, with the most recent change of +$13.25 million (+4.93%) on December 31, 2024.
  • During the last 3 years, SANA annual EBITDA has risen by +$90.51 million (+26.17%).
  • SANA annual EBITDA is now -83.26% below its all-time high of -$139.33 million, reached on December 31, 2019.

Performance

1-year change

+4.93%

3-year change

+26.17%

5-year change

-83.26%

15-year change

-

SANA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

5.65%
SANA annual EBITDA is higher than 5.65% of companies in Healthcare sector

Range

All-time high

-$139.33M

3-year low

-$345.84M

Earnings dates

Last annual earnings report date

Dec 31, 2024
SANA previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
SANA next annual earnings announcement has not yet been scheduled

OtherSANAincome statement metrics

Annual revenue

-
SANA annual revenue value is unknown

annual net income

-$266.76M
SANA annual net profit is -$266.76 million

annual EBIT

-$272.72M
SANA annual earnings before interest & taxes is -$272.72 million

Annual EPS

-$1.16
SANA annual earnings per share is -$1.16

quarterly EBITDA:

-$46.98M-$1.81M(-4.00%)
March 31, 2025

Summary

  • As of today (June 17, 2025), SANA quarterly EBITDA is -$46.98 million, with the most recent change of -$1.81 million (-4.00%) on March 31, 2025.
  • Over the past year, SANA quarterly EBITDA has increased by +$60.00 million (+56.08%).
  • SANA quarterly EBITDA is now -322.05% below its all-time high of $21.16 million, reached on June 30, 2021.

Performance

3-month change

-4%

1-year change

+56.08%

3-year change

-67.36%

5-year change

-46.77%

SANA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

9.4%
SANA quarterly EBITDA is higher than 9.4% of companies in Healthcare sector

Range

All-time high

$21.16M
SANA quarterly EBITDA is currently -322.05% below its historical high of $21.16 million

3-year low

-$111.84M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SANA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
SANA next earnings announcement is scheduled for Aug 8, 2025

OtherSANAincome statement metrics

Quarterly revenue

-
SANA quarterly revenue value is unknown

quarterly net income

-$49.39M
SANA quarterly net profit is -$49.39 million

quarterly EBIT

-$50.63M
SANA quarterly earnings before interest & taxes is -$50.63 million

Quarterly EPS

-$0.21
SANA quarterly earnings per share is -$0.21

TTM EBITDA:

-$195.34M+$60.00M(+23.50%)
March 31, 2025

Summary

  • As of today (June 17, 2025), SANA TTM EBITDA is -$195.34 million, with the most recent change of +$60.00 million (+23.50%) on March 31, 2025.
  • Over the past year, SANA TTM EBITDA has increased by +$100.52 million (+33.98%).
  • SANA TTM EBITDA is now -343.30% below its all-time high of -$44.06 million, reached on December 31, 2019.

Performance

3-month change

+23.5%

1-year change

+33.98%

3-year change

+0.04%

5-year change

-156.77%

SANA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

8.72%
SANA TTM EBITDA is higher than 8.72% of companies in Healthcare sector

Range

All-time high

-$44.06M

3-year low

-$351.31M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SANA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
SANA next earnings announcement is scheduled for Aug 8, 2025

OtherSANAincome statement metrics

TTM revenue

-
SANA TTM revenue value is unknown

TTM net income

-$208.67M
SANA TTM net profit is -$208.67 million

TTM EBIT

-$212.63M
SANA TTM earnings before interest & taxes is -$212.63 million

TTM EPS

-$0.88
SANA TTM earnings per share is -$0.88

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$255.33M
SANA annual EBITDA is -$255.33 million

annual net income

-$266.76M
SANA annual net profit is -$266.76 million

annual interest expense

-
SANA annual interest expense value is unknown

annual income tax

-
SANA annual income tax value is unknown

annual D&A

$17.39M
SANA annual depreciation & amortization is $17.39 million

SANA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.9%+56.1%+34.0%
3 y3 years+26.2%-67.4%+0.0%
5 y5 years-83.3%-46.8%-156.8%

SANA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+26.2%-2126.8%+58.0%at high+44.4%
5 y5-year-83.3%+26.2%-322.1%+73.7%-156.8%+54.2%
alltimeall time-83.3%+26.2%-322.1%+73.7%-343.3%+54.2%

SANA EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$46.98M(+4.0%)
-$195.34M(-23.5%)
Dec 2024
-$255.33M(-4.9%)
-$45.17M(-21.7%)
-$255.33M(-11.8%)
Sep 2024
-
-$57.70M(+26.9%)
-$289.51M(+26.2%)
Jun 2024
-
-$45.48M(-57.5%)
-$229.49M(-22.4%)
Mar 2024
-
-$106.98M(+34.8%)
-$295.86M(+10.2%)
Dec 2023
-$268.58M(+4.5%)
-$79.36M(-3523.4%)
-$268.58M(+0.7%)
Sep 2023
-
$2.32M(-102.1%)
-$266.82M(-24.0%)
Jun 2023
-
-$111.84M(+40.3%)
-$351.31M(+13.8%)
Mar 2023
-
-$79.71M(+2.7%)
-$308.57M(+20.1%)
Dec 2022
-$256.94M
-$77.59M(-5.6%)
-$256.94M(-10.6%)
Sep 2022
-
-$82.17M(+18.9%)
-$287.29M(+0.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$69.10M(+146.2%)
-$285.67M(+46.2%)
Mar 2022
-
-$28.07M(-74.0%)
-$195.41M(-43.5%)
Dec 2021
-$345.84M(+23.4%)
-$107.94M(+34.0%)
-$345.84M(-1.0%)
Sep 2021
-
-$80.55M(-480.7%)
-$349.46M(+9.5%)
Jun 2021
-
$21.16M(-111.9%)
-$319.04M(-25.2%)
Mar 2021
-
-$178.50M(+60.0%)
-$426.72M(+52.3%)
Dec 2020
-$280.23M(+101.1%)
-$111.57M(+122.6%)
-$280.23M(+31.7%)
Sep 2020
-
-$50.12M(-42.1%)
-$212.72M(+30.8%)
Jun 2020
-
-$86.53M(+170.3%)
-$162.60M(+113.7%)
Mar 2020
-
-$32.01M(-27.4%)
-$76.07M(+72.6%)
Dec 2019
-$139.33M
-$44.06M
-$44.06M

FAQ

  • What is Sana Biotechnology annual EBITDA?
  • What is the all time high annual EBITDA for Sana Biotechnology?
  • What is Sana Biotechnology annual EBITDA year-on-year change?
  • What is Sana Biotechnology quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Sana Biotechnology?
  • What is Sana Biotechnology quarterly EBITDA year-on-year change?
  • What is Sana Biotechnology TTM EBITDA?
  • What is the all time high TTM EBITDA for Sana Biotechnology?
  • What is Sana Biotechnology TTM EBITDA year-on-year change?

What is Sana Biotechnology annual EBITDA?

The current annual EBITDA of SANA is -$255.33M

What is the all time high annual EBITDA for Sana Biotechnology?

Sana Biotechnology all-time high annual EBITDA is -$139.33M

What is Sana Biotechnology annual EBITDA year-on-year change?

Over the past year, SANA annual EBITDA has changed by +$13.25M (+4.93%)

What is Sana Biotechnology quarterly EBITDA?

The current quarterly EBITDA of SANA is -$46.98M

What is the all time high quarterly EBITDA for Sana Biotechnology?

Sana Biotechnology all-time high quarterly EBITDA is $21.16M

What is Sana Biotechnology quarterly EBITDA year-on-year change?

Over the past year, SANA quarterly EBITDA has changed by +$60.00M (+56.08%)

What is Sana Biotechnology TTM EBITDA?

The current TTM EBITDA of SANA is -$195.34M

What is the all time high TTM EBITDA for Sana Biotechnology?

Sana Biotechnology all-time high TTM EBITDA is -$44.06M

What is Sana Biotechnology TTM EBITDA year-on-year change?

Over the past year, SANA TTM EBITDA has changed by +$100.52M (+33.98%)
On this page